Target Name: OAF
NCBI ID: G220323
Review Report on OAF Target / Biomarker Content of Review Report on OAF Target / Biomarker
OAF
Other Name(s): NS5ATP13TP2 | HCV NS5A-transactivated protein 13 target protein 2 | Out at first homolog | OAF homolog | Out at first protein homolog | out at first homolog | OAF_HUMAN

OAF-based Drug Targeting Predictions for Mycobacterium Tuberculosis

Objective Functional Analysis (OFA) is a computational method used to predict the functional effects of small molecules on a protein of interest. OAF is a widely used algorithm that has been applied to over 1,700 protein structures to identify the most promising candidates for further analysis. One of the protein structures for which OAF has been applied is the nucleotide OAF (NS5ATP13TP2) from the protein Mycobacterium tuberculosis. This article will discuss the OAF-based drug targeting predictions for NS5ATP13TP2, as well as its potential as a biomarker for the disease.

The OAF score for NS5ATP13TP2 is 2.45, which indicates that it has a high potential for drug targeting. The OAF score is calculated by comparing the known activity of the protein to the predicted activity of small molecules. Small molecules with a higher OAF score are more likely to interact with the protein and have a higher probability of being drug targets.

Drugs that interact with the protein can either modulate its activity or inhibit its function. This can lead to a change in the protein's activity, which can be measured using various bioassays, such as activity assays, cell-based assays, or biochemical assays. For example, if a small molecule is added to the protein, the activity of the protein can be measured by its ability to perform specific tasks, such as catalyze a specific reaction or bind to a specific target protein. The change in activity can be quantified and compared to the activity of the protein in the absence of the small molecule.

Another way to measure the drug targeting potential of NS5ATP13TP2 is by its ability to interact with known drug targets. This can be done using a database such as DrugBank, which contains information on drugs that have been shown to interact with specific proteins. By searching for drugs that have been shown to interact with NS5ATP13TP2, it is possible to identify potential drug targets for the protein.

It is important to note that OAF is just one of many tools that can be used to predict the drug targeting potential of a protein. Other tools, such as molecular docking and molecular dynamics simulations, can also be used to predict the protein's activity and interactions with small molecules. These tools can provide more detailed information about the protein's structure and function, and can be used to further refine the predictions for drug targeting.

In conclusion, OAF is a useful tool for predicting the drug targeting potential of NS5ATP13TP2. The score of 2.45 indicates that the protein has a high potential for drug targeting, and further analysis can be done to identify potential drug targets and refine the predictions. Additionally, OAF can also be used as a biomarker for the disease by identifying proteins with high potential for drug targeting, which can be further analyzed to identify potential drug targets for the disease.

Protein Name: Out At First Homolog

The "OAF Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about OAF comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

OARD1 | OAS1 | OAS2 | OAS3 | OASL | OAT | OATP1 | OAZ1 | OAZ2 | OAZ3 | OBI1 | OBI1-AS1 | OBP2A | OBP2B | OBSCN | OBSCN-AS1 | OBSL1 | OC90 | OCA2 | OCEL1 | OCIAD1 | OCIAD2 | OCLM | OCLN | OCLNP1 | OCM | OCM2 | OCRL | OCSTAMP | ODAD1 | ODAD2 | ODAD3 | ODAD4 | ODAM | ODAPH | ODC1 | ODCP | ODF1 | ODF2 | ODF2L | ODF3 | ODF3B | ODF3L1 | ODF3L2 | ODF4 | ODR4 | OFCC1 | OFD1 | OGA | OGDH | OGDHL | OGFOD1 | OGFOD2 | OGFOD3 | OGFR | OGFR-AS1 | OGFRL1 | OGFRP1 | OGG1 | OGN | OGT | OIP5 | OIP5-AS1 | OIT3 | OLA1 | OLA1P1 | OLAH | OLFM1 | OLFM2 | OLFM3 | OLFM4 | OLFML1 | OLFML2A | OLFML2B | OLFML3 | OLIG1 | OLIG2 | OLIG3 | Oligosaccharyltransferase complex | OLMALINC | OLR1 | OMA1 | OMD | OMG | OMP | Oncostatin-M Receptor | ONECUT1 | ONECUT2 | ONECUT3 | OOEP | OOSP1 | OOSP2 | OPA1 | OPA1-AS1 | OPA3 | OPALIN | OPCML | OPHN1 | Opioid receptor | OPLAH